title: Giant cell tumor of the pelvis: a systematic review.
abstract: This is a systematic review of articles concerning the morbidity, recurrence rate, treatment and treatment complications of pelvic giant cell tumors (GCTs). The key words "giant cell tumor, pelvis" were used to identify articles which included data on patients with pelvic GCTs in English and Chinese databases of published reports from 1949-2012. The articles were filtered by title, abstract and full text. Thirty-eight articles and 165 patients were identified for this review. Data on all identified patients were studies; data in different articles on the same patients was not used repeatedly. The following patient data were collected where possible and subjected to systematic analysis; age, location of GCT, treatment, follow-up, complications, recurrence and whether alive or dead. The mean age of onset was 33.2 years (range, 14-73 years), the peak ages of onset being between 21 and 40 years. A pronounced sex difference was identified, the male : female ratio being 1:1.7. The acetabulum was the commonest area for pelvic GCTs. Forty-eight tumors were primarily located in the iliac, 60 in the acetabular and 31 in the ischiopubic area. Twenty-seven patients experienced complications of treatment. Patients who had been treated by wide resection had the most complications; these included incisional infection and delayed healing of incisions. Local recurrence was common, having occurred in 39/158 patients (24.6%), comprising 24/72 (33.3%) who had undergone intralesional surgery only; 9/20 (45.0%) who had undergone radiotherapy only; 1/51 (2.0%) who had undergone wide resection; and 5/14 patients (35.7%) who had undergone radiation therapy or cryotherapy plus intralesional surgery. Mortality was low (3.2%, 5/158). Pelvic GCT is not common, the acetabular area appears to the most frequent site and the peak age is the third and fourth decades. Although the recurrence rate is high for all pelvic GCTs, the mortality is low. Treatment has a critical influence on recurrence. In spite of the associated complications, the lower local recurrence rate makes wide resection a reasonable option for patients with extensive and/or aggressive GCTs.
authors.affiliation: Department of Orthopaedics, General Hospital of Jinan Military Commanding Region, Jinan, China.
authors.forename: Kai
authors.initials: K
authors.lastname: Zheng
authors.affiliation: Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
authors.forename: Zhen
authors.initials: Z
authors.lastname: Wang
authors.affiliation: Department of Orthopaedics, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China.
authors.forename: Su-jia
authors.initials: SJ
authors.lastname: Wu
authors.affiliation: Department of Orthopaedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
authors.forename: Zhao-ming
authors.initials: ZM
authors.lastname: Ye
authors.affiliation: Department of Orthopaedics, General Hospital of Jinan Military Commanding Region, Jinan, China.
authors.forename: Song-feng
authors.initials: SF
authors.lastname: Xu
authors.affiliation: Department of Orthopaedics, General Hospital of Jinan Military Commanding Region, Jinan, China.
authors.forename: Ming
authors.initials: M
authors.lastname: Xu
authors.affiliation: Department of Bone Oncology, Tianjin Hospital, Tianjin, China.
authors.forename: Yong-cheng
authors.initials: YC
authors.lastname: Hu
authors.affiliation: Department of Orthopaedics, General Hospital of Jinan Military Commanding Region, Jinan, China.
authors.forename: Xiu-chun
authors.initials: XC
authors.lastname: Yu
mesh_terms: D001859:Bone Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D003131:Combined Modality Therapy; D018212:Giant Cell Tumor of Bone / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local; D010384:Pelvic Bones; D016896:Treatment Outcome
keywords: Giant cell tumors; Pelvis; Systematic review